AU2002337388A1 - Improvements in or relating to inhibition of viruses - Google Patents

Improvements in or relating to inhibition of viruses

Info

Publication number
AU2002337388A1
AU2002337388A1 AU2002337388A AU2002337388A AU2002337388A1 AU 2002337388 A1 AU2002337388 A1 AU 2002337388A1 AU 2002337388 A AU2002337388 A AU 2002337388A AU 2002337388 A AU2002337388 A AU 2002337388A AU 2002337388 A1 AU2002337388 A1 AU 2002337388A1
Authority
AU
Australia
Prior art keywords
viruses
inhibition
relating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002337388A
Other languages
English (en)
Inventor
Jamie Arnold
Jan Balzarini
Daniel Brown
Craig Cameron
Christian Castro
Jason Graci
Victoria Korneeva
David Loakes
Kei Moriyama
Kazuo Negishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0126701A external-priority patent/GB0126701D0/en
Application filed by Medical Research Council filed Critical Medical Research Council
Publication of AU2002337388A1 publication Critical patent/AU2002337388A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2002337388A 2001-11-07 2002-11-07 Improvements in or relating to inhibition of viruses Abandoned AU2002337388A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0126701A GB0126701D0 (en) 2001-11-07 2001-11-07 Improvements in or relating to induction of mutations in viruses
GB0126701.2 2001-11-07
US10/207,005 2002-07-30
US10/207,005 US7049303B2 (en) 2001-11-07 2002-07-30 Inhibition of viruses
PCT/GB2002/005031 WO2003039450A2 (en) 2001-11-07 2002-11-07 Improvements in or relating to inhibition of viruses

Publications (1)

Publication Number Publication Date
AU2002337388A1 true AU2002337388A1 (en) 2003-05-19

Family

ID=26246745

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002337388A Abandoned AU2002337388A1 (en) 2001-11-07 2002-11-07 Improvements in or relating to inhibition of viruses

Country Status (5)

Country Link
US (2) US7049303B2 (enExample)
EP (1) EP1441744A2 (enExample)
JP (1) JP2005507944A (enExample)
AU (1) AU2002337388A1 (enExample)
WO (1) WO2003039450A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7094768B2 (en) * 2002-09-30 2006-08-22 Genelabs Technologies, Inc. Nucleoside derivatives for treating hepatitis C virus infection
EP1572097A4 (en) * 2002-09-30 2010-02-17 Smithkline Beecham Corp NUCLEOSIDE DERIVATIVES FOR THE TREATMENT OF INFECTIONS WITH THE HEPATITIS C-VIRUS
CA2543116A1 (en) * 2003-10-27 2005-05-19 Genelabs Technologies, Inc. Methods for preparing 7-(2'-substituted-.szlig.-d-ribofuranosyl)-4-(nr2r3)-5-(substituted ethyn-1-yl)-pyrrolo[2,3-d]pyrimidine derivatives
BRPI0510929A (pt) 2004-06-18 2007-07-17 Chiron Corp derivados de n-(1-(1-benzil-4-fenil-1h-imidazol-2-il)-2,2-dimetilpropil) benzamida e compostos relacionados como inibidores de proteìna de eixo de kinesin (ksp) para o tratamento de cáncer
CA2600886A1 (en) * 2005-03-08 2006-09-14 Biota Scientific Management Pty Ltd. Bicyclic nucleosides and nucleotides as therapeutic agents
WO2009129120A2 (en) 2008-04-15 2009-10-22 Rfs Pharma, Llc Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections
ES2540964T3 (es) * 2009-06-08 2015-07-15 Takeda Pharmaceutical Company Limited Compuestos de dihidropirrolonaftiridinona como inhibidores de JAK
HK1214270A1 (zh) * 2012-10-29 2016-07-22 共晶制药股份有限公司 用於治療病毒感染和癌症的嘧啶核苷及其單磷酸酯前藥
JP7381190B2 (ja) 2014-12-26 2023-11-15 エモリー・ユニバーシテイ Ｎ４－ヒドロキシシチジン及び誘導体並びにそれに関連する抗ウイルス用途
PT3706762T (pt) 2017-12-07 2024-12-05 Univ Emory N4-hidroxicitidina e derivados e utilizações antivirais relacionadas com os mesmos
WO2023152709A1 (en) * 2022-02-14 2023-08-17 Arbutus Biopharma Corporation Rna polymerase inhibitors and methods using same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8802687D0 (sv) 1988-07-20 1988-07-20 Astra Ab Nucleoside derivatives
EP0375183A1 (en) 1988-12-05 1990-06-27 Schering Corporation Antiviral dimers and trimers
DK62592D0 (enExample) * 1992-05-14 1992-05-14 Novo Nordisk As
US5773424A (en) 1994-12-16 1998-06-30 Research Corporation Technologies, Inc. Treatment of toxoplasmosis
PT831852E (pt) 1995-06-07 2007-02-28 Uab Research Foundation Nucleósidos com actividade anti-vírus da hepatite b
BR9714349A (pt) 1996-10-16 2000-11-14 Icn Pharmaceuticals L-nucleosìdeos purina, seus análogos e utilizacões dos mesmos
NZ507848A (en) * 1996-10-28 2005-01-28 Univ Washington Method of increasing the mutation rate of a virus in a non-human by administering an RNA nucleoside analogue to a virally infected cell
WO1999043691A1 (en) 1998-02-25 1999-09-02 Emory University 2'-fluoronucleosides
IL133680A0 (en) 1999-09-10 2001-04-30 Can Fite Technologies Ltd Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
JP2003524636A (ja) 1999-12-22 2003-08-19 インスパイアー ファーマシューティカルズ，インコーポレイティド プリン性受容体アゴニストによる胃腸管の処置方法

Also Published As

Publication number Publication date
WO2003039450A2 (en) 2003-05-15
EP1441744A2 (en) 2004-08-04
US20030130226A1 (en) 2003-07-10
JP2005507944A (ja) 2005-03-24
US7049303B2 (en) 2006-05-23
WO2003039450A3 (en) 2003-08-21
US20050043268A1 (en) 2005-02-24

Similar Documents

Publication Publication Date Title
AU2002237124B2 (en) Compositions and methods relating to osteoarthritis
HUP0500042A3 (en) Use of hmg fragments as anti-inflammatory agents
AU2001234837A1 (en) Azapeptides useful in the treatment of hepatitis c
AU2002337388A1 (en) Improvements in or relating to inhibition of viruses
AU2001227972A1 (en) Methods to treat alpha-1-antitrypsin deficiency
AU2002355361A1 (en) Improvements in or relating to encapsulation
AU2001293048A1 (en) Antiviral compositions and methods of use
GB2373004B (en) Improvements in or relating to the protection of buildings
AU2002359792A1 (en) Methods and compositions for the inhibition of viral release
EP1439845A4 (en) INACTIVATION OF THE PAPILLOMA
WO2002083858A8 (en) Methods to inhibit viral replication
AU2002241162A1 (en) Intimins in the prevention or treatment of infections:ii
GB0100151D0 (en) Methods of sputtering
AU2001286052A1 (en) Improvements relating to water treatment
AU2994100A (en) Linked Bridge
AU2002323085A1 (en) Inhibition of viral replication by targeting rna-dna complexes
GB0118126D0 (en) Improvements in or relating to vapourisers
AU2002321556A1 (en) Inhibition of replication factor c
GB0122499D0 (en) Improvements in or relating to the removal of chemicals
AU2003241139A1 (en) Process and compositions for the purification of water
AU2002231976A1 (en) Improvements relating to the protection of buildings
AUPR788001A0 (en) Further improvements in the removal of phosphate from water
HK1064126A (en) Use of hmg fragments as anti-inflammatory agents
AUPR399701A0 (en) Determination of snoring
AU2002238705A1 (en) Improvements in or relating to security devices

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase